Targeted peptide measurements in biology and medicine: Best practices for mass spectrometry-based assay development using a fit-for-purpose approach

Molecular and Cellular Proteomics

Volumn 13, Issue 3, 2014, Pages 907-917

  Carr, Steven A ^a   Abbatiello, Susan E ^a   Ackermann, Bradley L ^b   Borchers, Christoph ^c   Domon, Bruno ^d   Deutsch, Eric W ^e   Grant, Russell P ^f   Hoofnagle, Andrew N ^g   Hüttenhain, Ruth ^h,i   Koomen, John M ^j   Liebler, Daniel C ^k   Liu, Tao ^l   MacLean, Brendan ^g   Mani, D R ^a   Mansfield, Elizabeth ^m   Neubert, Hendrik ⁿ   Paulovich, Amanda G ^o   Reiter, Lukas ^p   Vitek, Olga ^q   Aebersold, Ruedi ^h   Anderson, Leigh ^r   Bethem, Robert ^s   Blonder, Josip ^t   Boja, Emily ^t   Botelho, Julianne ^u   Boyne, Michael ^m   Bradshaw, Ralph A ⁱ   Burlingame, Alma L ⁱ   Chan, Daniel ^v   Keshishian, Hasmik ^a   Kuhn, Eric ^a   Kinsinger, Christopher ^t   Lee, Jerry S H ^t,v   Lee, Sang Won ^w   Moritz, Robert ^e   Oses Prieto, Juan ⁱ   Rifai, Nader ^x   Ritchie, James ^y   Rodriguez, Henry ^t   Srinivas, Pothur R ^z   Townsend, R Reid ^aa   Van Eyk, Jennifer ^v   Whiteley, Gordon ^ab   Wiita, Arun ⁱ   Weintraub, Susan ^ac   more..

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF VICTORIA   (Canada)

^d Luxembourg Clinical Proteomics Center   (Luxembourg)

^e INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^f LABORATORY CORPORATION OF AMERICA   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h ETH ZURICH   (Switzerland)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^k VANDERBILT UNIVERSITY   (United States)

^l PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^m CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

ⁿ PFIZER INC   (United States)

^o Fred Hutchinson Cancer Research Center   (United States)

^p Biognosys Schlieren   (Switzerland)

^q PURDUE UNIVERSITY   (United States)

^r SISCAPA Assay Technologies Inc   (United States)

^s RAB Consulting   (United States)

^t NATIONAL CANCER INSTITUTE   (United States)

^u CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^v JOHNS HOPKINS UNIVERSITY   (United States)

^w Korea University   (South Korea)

^x BOSTON CHILDREN S HOSPITAL   (United States)

^y EMORY UNIVERSITY   (United States)

^z NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^aa WASHINGTON UNIVERSITY   (United States)

^ab FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^ac UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; STABLE ISOTOPE;

ARTICLE; CELL LYSATE; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEOMICS; QUANTITATIVE ASSAY; RELIABILITY; REPRODUCIBILITY; STANDARD;

ANIMALS; BIOLOGICAL ASSAY; BIOLOGY; GUIDELINES AS TOPIC; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; MEDICINE; PEPTIDES; PROTEOMICS; REFERENCE STANDARDS; SOFTWARE;

EID: 84895555123     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.036095     Document Type: Article

References (99)

1. Gillette, M. A., and Carr, S. A. (2013) Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods 10, 28-34
2. Picotti, P., and Aebersold, R. (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 9, 555-566
3. Grebe, S. K. G., and Singh, R. J. J. (2011) LC-MS/MS in the clinical laboratory - where to from here? Clin. Biochem. Rev. 32, 5-31
4. Lawson, A. M. (1975) The scope of mass spectrometry in clinical chemistry. Clin. Chem. 21, 803-824
5. Parsons, H. G. (1990) Stable isotopes in the management and diagnosis of inborn errors of metabolism. Can. J. Physiol. Pharmacol. 68, 950-954
6. Brumley, W. C., and Sphon, J. A. (1981) Regulatory mass spectrometry. Biomed. Mass Spectrom. 8, 390-396
7. Sphon, J. A. (1978) Use of mass spectrometry for confirmation of animal drug residues. J. Assoc. Off. Anal. Chem. 61, 1247-1252
8. Vargo, J. D. (1998) Determination of sulfonic acid degradates of chloroacetanilide and chloroacetamide herbicides in groundwater by LC/MS/MS. Anal. Chem. 70, 2699-2703
9. Kuhara, T. (2007) Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. J. Chromatog. 855, 42-50
10. Pitt, J. J., Eggington, M., and Kahler, S. G. (2002) Comprehensive screening of urine samples from inborn errors of metabolism by electrospray tandem mass spectrometry. Clin. Chem. 48, 1970-1980
11. Timmerman, P., Anders, Kall, M., Gordon, B., Laakso, S., Freisleben, A., and Hucker, R. (2010) Best practices in a tiered approach to metabolite quantification: Views and recommendations of the European Bioanalysis Forum. Bioanalysis 2, 1185-1194
12. Timmerman, P., Herling, C., Stoellner, D., Jaitner, B., Pihl, S., Elsby, K., Henderson, N., Barroso, B., Fischmann, S., Companjen, A., Versteilen, A., Bates, S., Kingsley, C., and Kunz, U. (2012) European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development. Bioanalysis 4, 1883-1894
13. Timmerman, P., Lausecker, B., Barosso, B., van Amsterdam, P., Luedtke, S., and Dijksman, J. (2012) 'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LCMS(/ MS). Bioanalysis 4, 627-631
14. Thompson, M., and Ramsey, M. H. (1995) Quality concepts and practices applies to sampling - an exploratory study. Analyst 120, 261-270
15. Bethem, R., and Boyd, R. K. (1998) Mass spectrometry in trace analysis. J. Amer. Soc. Mass Spectrom. 9, 643-648
16. Bethem, R., Boison, J., Gale, J., Heller, D., Lehotay, S., Loo, J., Musser, S., Price, P., and Stein, S. (2003) Establishing the fitness for purpose of mass spectrometric methods. J. Amer. Soc. Mass Spectrom. 14, 528-541
17. Lee, J. W., Devanarayan, V., Barrett, Y. C., Weiner, R., Allinson, J., Fountain, S., Keller, S., Weinryb, I., Green, M., Duan, L., Rogers, J. A., Millham, R., O'Brien, P. J., Sailstad, J., Khan, M., Ray, C., and Wagner, J. A. (2006) Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23, 312-328
18. Lee, J. W., Figeys, D., and Vasilescu, J. (2007) Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. Adv. Cancer Res. 96, 269-298
19. Cummings, J., Raynaud, F., Jones, L., Sugar, R., and Dive, C., on behalf of the Bioanalysis and Quality Assurance (BAQA) Group of the ECMC (2010) Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br. J. Cancer 103, 1313-1317
20. Carr, S. A., Aebersold, R., Baldwin, M., Burlingame, A., Clauser, K., and Nesvizhski, A. (2004) The need for guidelines in publication of peptide and protein identification data. Mol. Cell. Proteomics 3, 531-533
21. Bradshaw, R. A., Burlingame, A. L., Carr, S., and Aebersold R. (2006) Reporting protein identification data: the next generation of guidelines. Mol. Cell. Proteomics. 5, 787-788
22. Chalkley, R. J., Clauser, K. R., and Carr, S. A. (2009) Updating the MCP Proteomic publication guidelines. ASBMB Today, 16-17
23. http://www.mcponline.org.libproxy.mit.edu/site/misc/PhialdelphiaGuide linesFINALDRAFT.pdf
24. Guidance for Industry: Bioanalytical Method Validation. (2001) US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, U.S.A. (Rev. 1, September, 2013)
25. (2011) Guideline on Bioanalytical Method Validation. EMA, Committee for Medicinal Products for Human Use, London, UK
26. DeSilva et al. (2012) White paper on recent issues in bioanalysis and alignment of multiple guidelines. Bioanalysis 4, 2213-2226
27. Barr, J.R., Maggio, V.L., Patterson, D.G., Jr., Cooper, G.R., Henderson, L.O., Turner, W.E., et al. (1996) Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 42, 1676-1682
28. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., and Gygi, S. P. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Nat. Acad. Sci. 100, 6940-6945
29. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., and Carr, S. A. (2007) Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2, 2212
30. Berna, M. J., Ott, L., Engle, S., Watson, D., Solter, P., and Ackermann, B. (2008) Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a Biomarker of drug-induced cardiac hypertrophy. Anal. Chem. 80, 561-566
31. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A. J. L., Keshishian, H., Hall, S. C., Allen, S., Blackman, R. K., Borchers, C. H., Buck, C., Cardasis, H. L., Cusack, M. P., Dodder, N. G., Gibson, B. W., Held, J. M., Hiltke, T., Jackson, A., Johansen, E. B., Kinsinger, C. R., Li, J., Mesri, M., Neubert, T. A., Niles, R. K., Pulsipher, T. C., Ransohoff, D., Rodriguez, H., Rudnick, P. A., Smith, D., Tabb, D. L., Tegeler, T. J., Variyath, A. M., Vega-Montoto, L. J., Wahlander, A., Waldemarson, S., Wang, M., Whiteaker, J. R., Zhao, L., Anderson, N. L., Fisher, S. J., Liebler, D. C., Paulovich, A. G., Regnier, F. E., Tempst, P., and Carr, S. A. (2009) Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27, 633-685
32. Picotti, P., Bodenmiller, B., Mueller, L. N., Domon, B., and Aebersold, R. (2009) Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138, 795-806. doi: 10.1016/j.cell.2009.05.051. Epub 2009 Aug 6
33. Whiteaker, J. R., Zhao, L., Abbatiello, S. E., Burgess, M., Kuhn, E., Lin, C. W., Pope, M. E., Razavi, M., Anderson, N. L., Pearson, T. W., Carr, S. A., and Paulovich, A. G. (2011) Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol. Cell. Proteomics 10, M110.005645
34. Shi, T., Fillmore, T. L., Sun, X., Zhao, R., Schepmoes, A. A., Hossain, M., Xie, F., Wu, S., Kim, J. S., Jones, N., Moore, R. J., Pasa-Tolic, L., Kagan, J., Rodland, K. D., Liu, T., Tang, K., Camp, D. G., Smith, R. D., and Qian, W. J. (2012) Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc. Natl. Acad. Sci. U.S.A. 109, 15395-15400
35. Wang, Q., Chaerkady, R., Wu, J., Hwang, H. J., Papadopoulos, N., Kopelovich, L., Maitra. A., Matthaei, H., Eshleman, J. R., Hruban, R. H., Kinzler, K. W., Pandey, A., and Vogelstein, B. (2011) Mutant proteins as cancerspecific biomarkers. Proc. Natl. Acad. Sci. U.S.A. 108, 2444-2449
36. Addona, T. A., Shi, X., Keshishian, H., Mani, D. R., Burgess, M., Gillette, M. A., Clauser, K. R., Shen, D., Lewis, G. D., Farrell, L. A., Fifer, M. A., Sabatine, M. S., Gerszten, R. E., and Carr, S. A. (2011) A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 29, 635-643
37. Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., Kelly-Spratt, K. S., Krasnoselsky, A., Gafken, P. R., Hogan, J. M., Jones, L. A., Wang, P., Amon, L., Chodosh, L. A., Nelson, P. S., McIntosh, M. W., Kemp, C. J., and Paulovich, A. G. (2011) A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotech. 29, 625-634
38. Domanski, D., Percy, A. J., Yang, J., Chambers, A. G., Hill, J. S., Freue, G. V., and Borchers, C. H. (2012) MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 12, 1222-1243
39. Pan, S., Chen, R., Brand, R. E., Hawley, S., Tamura, Y., Gafken, P. R., Milless, B. P., Goodlett, D. R., Rush, J., and Brentnall, T. A. (2012) Multiplex targeted proteomic assay for biomarker detection in plasma: A pancreatic cancer biomarker case study. J. Proteome Res. 11, 1937-1948
40. Huttenhain, R., Soste, M., Selevsek, N., Rost, H., Sethi, A., Carapito, C., Farrah, T., Deutsch, E. W., Kusebauch, U., Moritz R. L., Nimeus-Malmstrom, E., Rinner, O., and Aebersold, R. (2012) Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 4, 1-13
41. Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Abraham, D., Hoofnagle, A. N., and Meikle, A. W. (2013) Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clinical Chemistry 59, 982-990
42. Neubert, H., Muirhead, D., Kabir, M., Grace, C., Cleton, A., and Arends, R. (2013) Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human beta-nerve growth factor. Anal. Chem. 85, 1719-1726
43. Rifai, N., Gillette, M. A., and Carr, S. A. (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983
44. Brun, V., Masselon, C., Garin, J., and Dupuis, A. (2009) Isotope dilution strategies for absolute quantitative proteomics. J. Proteomics 72, 740-749
45. Kuzyk, M. A., Smith, D., Yang, J. C., Cross, T. J., Jackson, A. M., Hardie, D. B., Anderson, N. L., and Borchers, C. H. (2009) Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 8, 1860-1877
46. Shuford, C. M., Sederoff, R. R., Chiang, V. L., and Muddiman, D. C. (2012) Peptide production and decay rates affect the quantitative accuracy of protein cleavage isotope dilution mass spectrometry (PC-IDMS). Mol. Cell. Proteomics 11, 814-823
47. Matuszewski, B. K., Constanzer, M. L., and Chavez-Eng, C. M. (1998) Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 70, 882-889
48. King, R., Bonfiglio, R., Fernandez-Metzler, C., Miller-Stein, C., and Olah, T. (2000) Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 11, 942-950
49. Abbatiello, S. E., Mani, D. R., Keshishian, H., and Carr, S. A. (2010) Automated Detection of inaccurate and imprecise transitions in quantitative assays of peptides by multiple monitoring mass spectrometry. Clin. Chem. 56, 291-305
50. Reiter, L., Rinner, O., Picotti, P., Hüttenhain, R., Beck, M., Brusniak, M. Y., Hengartner, M. O., and Aebersold, R. (2011) mProphet: automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 8, 430-435
51. Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., and Carr, S. A. (2009) Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 8, 2339-2349
52. Brun, V., Dupuis, A., Adrait, A., Marcellin, M., Thomas, D., Court, M., Vandenesch, F., and Garin, J. (2007) Isotope-labeled protein standards. Mol. Cell. Proteomics 6, 2139-2149
53. Singh, R., Crow, F. W., Babic, N., Lutz, W. H., Lieske, J. C., Larson, T. S., and Kumar, R. (2007) A liquid chromatography-mass spectrometry method for the quantification of urinary albumin using a novel N-15- isotopically labeled albumin internal standard. Clin. Chem. 53, 540-542
54. Kito, K., and Ito, T. (2008) Mass spectrometry-based approaches toward absolute quantitative proteomics. Current Genomics 9, 263-274
55. Picard, G., Lebert, D., Louwagie, M., Adrait, A., Huillet, C., Vandenesch, F., Bruley, C., Garin, J., Jaquinod, M., and Brun, V. (2012) PSAQ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications. J. Mass Spectrom. 47, 1353-1363
56. Kuhn, E., Whiteaker, J. R., Mani, D. R., Jackson, A. M., Zhao, L., Pope, M. E., Smith, D., Rivera, K. D., Anderson, N. L., Skates, S. J., Pearson, T. W., Paulovich, A. G., and Carr, S. A. (2012) Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol. Cell. Proteomics 11, M111.013854
57. Paulovich, A. G., Whiteaker, J. R., Hoofnagle, A. N., and Wang, P. (2008) The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline. Proteomics Clin. Appl. 2, 1386-1402
58. Remily-Wood, E. R., Liu, R. Z., Xiang, Y., Chen, Y., Thomas, C. E., Rajyaguru, N., Kaufman, L. M., Ochoa, J. E., Hazlehurst, L., Pinilla-Ibarz, J., Lancet, J., Zhang, G. L., Haura, E., Shibata, D., Yeatman, T., Smalley, K. S. M., Dalton, W. S., Huang, E. N., Scott, E., Bloom, G. C., Eschrich, S. A., and Koomen, J. M. (2011) A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer. Proteomics Clin. Appl. 5, 383-396
59. Gallien, S., Duriez, E., Crone, C., Kellmann, M., Moehring, T., and Domon, B. (2012) Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol. Cell. Proteomics 11, 1709-1723
60. Oberg, A. L., and Vitek, O. (2009) Statistical design of quantitative mass spectrometry-based proteomic experiments. J. Proteome Res. 8, 2144-2156
61. Beynon, R. J., Doherty, M. K., Pratt, J. M., and Gaskell, S. J. (2005) Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides. Nat. Methods 2, 587
62. Linnet, K. (1993) Evaluation of regression procedures for methods comparison studies. Clin. Chem. 39, 424-432
63. Currie, L. A. (1968) Limits for qualitative detection and quantitative determination. Anal. Chem. 40, 586-593
64. Linnet, K., and Kondratovichm M. (2004) Partly nonparametric approach for determining the limit of detection. Clin. Chem. 50, 732-740
65. Mani, D. R., Abbatiello, S. E., and Carr, S. A. (2012) Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics. Bioinformatics 13, S9
66. Li, W., and Cohen, L.H. (2003) Quantitation of endogenous analytes in biofluid without a true blank matrix Anal. Chem. 75, 5854-5859
67. Whiteaker, J. R., Zhao, L., Lin, C., Yan, P., and Paulovich, A. G. (2011) Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry Mol. Cell. Proteomics 10.1074/mcp.M111.015347
68. Kuhn, E., Ross, J., Abbatiello, S. E., Mani, D. R., and Carr, S. A. (2012) Reversing the Curve: Determining LOD in the Presence of Endogenous Signal using SID-MRM-MS. Presented at the 60th Annual Conference on Mass Spectrometry, Monday poster MP01, poster number 004
69. Abbatiello, S. E., Mani, D. R., Schilling, B., Maclean, B., Zimmerman, L. J., Feng, X., Cusack, M. P., Sedransk, N., Hall, S. C., Addona, T., Allen, S., Dodder, N. G., Ghosh, M., Held, J. M., Hedrick, V., Inerowicz, H. D., Jackson, A., Keshishian, H., Kim, J. W., Lyssand, J. S., Riley, C. P., Rudnick, P., Sadowski, P., Shaddox, K., Smith, D., Tomazela, D., Wahlander, A., Waldemarson, S., Whitwell, C. A., You, J., Zhang, S., Kins-inger, C. R., Mesri, M., Rodriguez, H., Borchers, C. H., Buck, C., Fisher, S. J., Gibson, B. W., Liebler, D., Maccoss, M., Neubert, T. A., Paulovich, A., Regnier, F., Skates, S. J., Tempst, P., Wang, M., and Carr, S. A. (2013) Design, implementation, and multi-site evaluation of a system suitability protocol for the quantitative assessment of instrument performance in LC-MRM-MS. Mol. Cell. Proteomics 12, 2623-2639. doi: 10.1074/mcp.M112.027078
70. Neubert, H., Gale, J., and Muirhead, D. (2010) Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: Assay development for total salivary pepsin/pepsinogen. Clin. Chem. 56, 1413-1423
71. Li, W., Nemirovskiy, O., Fountain, S., Mathews, W. R., and Szekely-Klepser, G. (2007) Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Anal. Biochem. 369, 41-53
72. Bantscheff, M., Lemeer, S., Savitski, M. M., and Kuster, B. (2012) Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal. Bioanal. Chem. 404, 939-965
73. Rochat, B., Peduzzi, D., McMullen, J., Favre, A., Kottelat, E., Favrat, B., Tissot, J. D., Angelillo-Scherrer, A., Bromirski, M., and Waldvogel, S. (2013) Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform. Bioanalysis 5, 2509-2520
74. Jaffe, J. D., Wang, Y., Chan, H. M., Zhang, J., Huether, R., Kryukov, G. V., Bhang, H. E., Taylor, J. E., Hu, M., Englund, N. P, Yan, F., Wang, Z., McDonald, R. E., 3rd, Wei, L., Ma, J., Easton, J., Yu, Z., Debeaumount, R., Gibaja, V., Venkatesan, K., Schlegel, R., Sellers, W. R., Keen, N., Liu, J., Caponigro, G., Barretina, J., Cooke, V. G., Mullighan, C., Carr, S. A., Downing, J. R., Garraway, L. A., and Stegmeier, F. (2013) Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 45, 1386-1391, Epub 2013 Sep 29
75. Fenyö, D., Eriksson, J., and Beavis, R. (2010) Mass spectrometric protein identification using the global proteome machine. Methods Mol Biol. 673, 189-202
76. Deutsch, E. W. (2010) The peptideatlas project. Methods Mol. Biol. 604, 285-296
77. Vizcaíno, J. A., Cô té, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Perez-Riverol, Y., Reisinger, F., Ríos, D., Wang, R., and Hermjakob, H. (2013) The proteomics identifications (PRIDE) database and associated tools: Status in 2013. Nucleic Acids Res. 41 (Database issue), D1063-D1069, Epub 2012 Nov 29
78. Picotti, P., Lam, H., Campbell, D., Deutsch, E. W., Mirzaei, H., Ranish, J., Domon, B., and Aebersold, R. (2013) A database of mass spectrometric assays for the yeast proteome. Mol. Cell. Proteomics 12, 1005-1016
79. Hü ttenhain, R., Surinova, S., Ossola, R., Sun, Z., Campbell, D., Cerciello, F., Schiess, R., Bausch-Fluck, D., Rosenberger, G., Chen, J., Rinner, O., Kusebauch, U., Hajdú ch, M., Moritz, R. L, Wollscheid, B., and Aebersold, R. (2013) N-glycoprotein SRMAtlas: A resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications. Mol. Cell. Proteomics 12, 1005-1016
80. Venable, J. D., Dong, M. Q., Wohlschlegel, J., Dillin, A., and Yates, J. R. (2004) Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods 1, 39-45
81. Huang, X., Liu, M., Nold, M. J., Tian, C., Fu, K., Zheng, J., Geromanos, S. J., and Ding, S. J. (2011) Software for quantitative proteomic analysis using stable isotope labeling and data independent acquisition. Anal. Chem. 15, 6971-6979. doi: 10.1021/ac201555m. Epub 2011 Aug 23
82. Gillet, L. C., Navarro, P., Tate, S., Rö st, H., Selevsek, N., Reiter, L., Bonner, R., and Aebersold, R. (2012) Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11, 10.1074/mcp.O111.016717. Epub 2012 Jan 18
83. Egertson, J. D., Kuehn, A., Merrihew, G. E., Bateman, N. W., Maclean, B. X., Ting, Y. S., Canterbury, J. D., Marsh, D. M., Kellmann, M., Zabrouskov, V., Wu, C. C., and Maccoss, M. J. (2013) Multiplexed MS/MS for improved data-independent acquisition. Nat. Methods 10, 744-746. 10.1038/nmeth. 2528. Epub 2013 Jun 23
84. Panchaud, A., Scherl, A., Shaffer, S. A., von Haller, P. D., Kulasekara, H. D., Miller, S. I., and Goodlett, D. R. (2009) Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. Anal. Chem. 81, 6481-6488. 10.1021/ac900888s
85. Escher, C., Reiter, L., MacLean, B., Ossola, R., Herzog, F., Chilton, J., MacCoss, M. J., and Rinner, O. (2012) Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111-1121. 10.1002/pmic. 201100463
86. Picotti, P., Rinner, O., Stallmach, R., Dautel, F., Farrah, T., Domon, B., Wenschuh, H., and Aebersold, R. (2010) High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat. Methods 7, 43-46. 10.1038/nmeth. 1408. Epub 2009 Dec 6
87. Zhang, H., Liu, Q., Zimmerman, L. J., Ham, A. J., Slebos, R. J., Rahman, J., Kikuchi, T., Massion, P. P., Carbone, D. P., Billheimer, D., and Liebler, D. C. (2011) Methods for peptide and protein quantitation by liquid chromatography- multiple reaction monitoring mass spectrometry. Mol. Cell. Proteomics 10, 10.1074/mcp.M110.006593. Epub 2011 Feb 27
88. Tang, H. Y., Beer, L. A., Barnhart, K. T., and Speicher, D. W. (2011) Rapid verification of candidate serological biomarkers using gel-based, labelfree multiple reaction monitoring. J. Proteome Res. 10, 4005-4017 10.1021/pr2002098. Epub 2011 Jul 26
89. Sherrod, S. D., Myers, M. V., Li, M., Myers, J. S., Carpenter, K. L., Maclean, B., Maccoss, M. J., Liebler, D. C., and Ham, A. J. (2012) Label-free quantitation of protein modifications by pseudo selected reaction monitoring with internal reference peptides. J. Proteome Res. [Epub ahead of print]
90. Colangelo, C. M., Chung, L., Bruce, C., and Cheung, K. H. (20130 Review of software tools for design and analysis of large scale MRM proteomic datasets. Methods 61, 287-298. 10.1016/j.ymeth. 2013.05.004. Epub 2013 May 21
91. Brusniak, M. Y., Chu, C. S., Kusebauch, U., Sartain, M. J., Watts, J. D., and Moritz, R. L. (2012) An assessment of current bioinformatic solutions for analyzing LC-MS data acquired by selected reaction monitoring technology. Proteomics 12, 1176-1184. 10.1002/pmic. 201100571
92. General Principles of Software Validation; Final Guidance for Industry and FDA Staff. Document issued on: January 11, 2002. This document supersedes the draft document, "General Principles of Software Validation, Version 1.1, dated June 9, 1997. http://www.fda.gov/downloads/ RegulatoryInformation/ Guidances/ucm126955.pdf
93. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., and MacCoss, M. J. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968. 10.1093/bioinformatics/ btq054. Epub 2010 Feb 9
94. http://genepattern.broadinstitute.org/gp/pages/index.jsf?lsid-QuaSAR. Note that you must register on the Genepattern website in order to access. Registration is free
95. Surinova, S., Hü ttenhain, R., Chang, C. Y., Espona, L., Vitek O., and Aebersold, R. (2013) Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies. Nature Protocols 8, 1602-1619
96. Farrah, T., Deutsch, E. W., Kreisberg, R., Sun, Z., Campbell, D. S., Mendoza, L., Kusebauch, U., Brusniak, M. Y., Huttenhain, R., Schiess, R., Selevsek, N., Aebersold, R., and Moritz, R. L. (2012) PASSEL: The PeptideAtlas SRM experiment library. Proteomics 12, 1170-1175
97. Martínez-Bartolomé, S., Deutsch, E. W., Binz, P. A., Jones, A. R., Eisenacher, M., Mayer, G., Campos, A., Canals, F., Bech-Serra, J. J., Carrascal, M., Gay, M., Paradela, A., Navajas, R., Marcilla, M., Herná ez, M. L., Gutié rrez-Blá zquez, M. D., Velarde, L. F., Aloria, K., Beaskoetxea, J., Medina-Aunon, J. A., and Albar, J. P. (2013) Guidelines for reporting quantitative mass spectrometry based experiments in proteomics. J. Proteomics in press
98. Russell, J. F. (2013) If a job is worth doing, it is worth doing twice. Nature (2013) 496: 7 and Editorial Staff. Reducing our irreproducibility. Nature 496, 398
99. Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., and Coon, J. J. (2012) Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11, 10.1074/mcp.O112.020131:1475-1488